Quantcast
News

College Hockey:
Setback for Yale’s Schwartz in Battle With Leukemia

Tests have indicated that Yale’s Mandi Schwartz is no longer in remission in her battle with acute myeloid leukemia, a development that has postponed her stem cell transplant.

Schwartz needs to be in remission to have the transplant, so she will undergo more chemotherapy.

Her doctors at Fred Hutchinson Cancer Care Center in Seattle have developed what’s being called a breakthrough procedure in the stem cell transplant that is being planned for when Schwartz is again in remission.

For more information, see yalebulldogs.com.


The following is a self-policing forum for discussing views on this story. Comments that are derogatory, make personal attacks, are abusive, or contain profanity or racism will be removed at our discretion. USCHO.com is not responsible for comments posted by users. Please report any inappropriate or offensive comments by clicking the “Flag” link next to that comment in order to alert the moderator.

Please also keep “woofing,” taunting, and otherwise unsportsmanlike behavior to a minimum. Your posts will more than likely be deleted, and worse yet, you reflect badly on yourself, your favorite team and your conference.